Furthermore, western blot analysis further confirmed that BIBF1000 treatment attenuated the lung expression of α-SMA, PCNA, iNOS, MMP-2, MMP-9, and COX-2, compared to vehicle-treated asthma lung tissues (Fig. 7A–G). The gene discussed is ACTA1; the disease is asthma.